Festive Symposium 2025: Delivering Neuroscience: From Synapse to Society

John Isaac

Chief Scientific Officer, Aviadabio

John brings more than 30 years of experience in academia, non-profit and industry. He’s an internationally recognized neuroscientist, originally with a focus on synaptic mechanisms in circuit function and how dysfunction causes psychiatric and neurological disease, and latterly on the cellular and molecular mechanisms of neurodegeneration. Most recently at Johnson & Johnson Innovation, John served as Head of Neuroscience, External Innovation, EMEA where he oversaw neuroscience partnerships and assets in EMEA spanning Discovery through Phase 2 development, as well as related business development activities, including the spinout of AviadoBio. Prior to that, he held several roles in various organizations, including leading the neuroscience strategy and funding at the Wellcome Trust and at Eli Lilly & Co, UK where he led a team of labs dedicated to identifying new treatments for psychiatry and neurodegeneration, including Parkinson’s and Alzheimer’s disease.

John received a bachelor’s degree in biochemistry and pharmacology, and a PhD in neuroscience from University of Southampton, UK, and has held academic faculty positions in the UK and USA.

: https://aviadobio.com/team/